FindTrial
Sign In

New biomarkers in patients with severe COVID-19 in University of South China:a prospective cohort study

New biomarkers in patients with severe COVID-19:a prospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067413
Enrollment
Unknown
Registered
2023-01-06
Start date
2023-01-03
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Case series:NA

Sponsors

University of South China
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participants who have a positive SARS-CoV-2 test result. Participants who have one or more of the following requirements: =7 days from the first positive test for SARS-COV-2 virus infection to Day 1; =5 days from the first onset of COVID-19 symptoms to Day 1. Participants who satisfy one or more than one of the following high risks for progression to severe COVID-19, including death.

Exclusion criteria

Exclusion criteria: Participants who are judged by the investigator whose life expectancy is less than one week.

Design outcomes

Primary

MeasureTime frame
30-day mortality;ventilator-free days;90-day mortality;—

Countries

China

Contacts

Public ContactZhihan Tang

University of South China

tangzhihan98@163.com13574780245

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026